Table 2. Statistical analysis of miR-410 expression with clinicopathological characteristics in human NSCLC tumor specimens.
MiR-410 expression | Metastasis | P value | Differentiation | P value | ||
---|---|---|---|---|---|---|
Yes | No | Low | Medium | |||
Downregulation | 7 (7/16) | 10 (10/20) | 0.709 | 6 (6/19) | 11 (11/17) | 0.047* |
Upregulation | 9 (9/16) | 10 (10/20) | 0.709 | 13 (13/19) | 6 (6/17) | 0.047* |
P by Χ2 test; *P < 0.05.